Rüdiger B. Müller

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 marketed ·

Quick facts

Marketed products

IV Abatacept · Immunology
Abatacept is a fusion protein that blocks T-cell costimulation by binding to CD80/CD86 on antigen-presenting cells, thereby inhibiting T-cell activation and proliferation.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Rüdiger B. Müller portfolio CI brief
Rüdiger B. Müller pipeline updates RSS

Frequently asked questions about Rüdiger B. Müller

What are Rüdiger B. Müller's marketed drugs?

Top marketed products include IV Abatacept.

IV Abatacept · Immunology
Sector hub: All tracked pharma companies